Theraclion SA (ALTHE) EUR0.05

Sell:€0.82Buy:€0.84Price increased€0.08 (10.81%)

Market closed |
Prices delayed by at least 15 minutes
Sell:€0.82
Buy:€0.84
Change:Price increased€0.08 (10.81%)
Market closed |
Prices delayed by at least 15 minutes
Sell:€0.82
Buy:€0.84
Change:Price increased€0.08 (10.81%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 May 2026
Cedric BellangerDirector
Sell
Regular sell transaction (market)
25,207€0.70€17,644.900
13 May 2026
Martin DeterreCEO
Sell
Regular sell transaction (market)
510,983€0.00€1,788.440
3 February 2026
Cedric BellangerDirector
Sell
Regular sell transaction (market)
7,339€0.70€5,137.300
26 September 2025
Cedric BellangerDirector
Sell
Regular sell transaction (market)
17,505€0.82€14,294.580
25 September 2025
Cedric BellangerDirector
Sell
Regular sell transaction (market)
48,320€0.88€42,376.640
17 September 2025
Cedric BellangerDirector
Sell
Regular sell transaction (market)
187€0.90€168.300
16 September 2025
Cedric BellangerDirector
Sell
Regular sell transaction (market)
1,493€0.96€1,433.280

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
25 September 2025
Cedric BellangerDirector
Sell
Regular sell transaction (market)
48,320€0.88€42,376.640
28 May 2026
Cedric BellangerDirector
Sell
Regular sell transaction (market)
25,207€0.70€17,644.900
26 September 2025
Cedric BellangerDirector
Sell
Regular sell transaction (market)
17,505€0.82€14,294.580
3 February 2026
Cedric BellangerDirector
Sell
Regular sell transaction (market)
7,339€0.70€5,137.300
13 May 2026
Martin DeterreCEO
Sell
Regular sell transaction (market)
510,983€0.00€1,788.440

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.